Furthermore, radiation and anti-CD95 treatment may stimulate the release and presentation of tumor antigens to antigen-presenting cells (APCs), such as dendritic cells (DCs), and enhance their cross-presentation to cytotoxic T cells (CTLs), leading to the activation of CTLs and their infiltration into the tumor microenvironment. The gene discussed is FAS; the disease is neoplasm.